Next-Generation Biomanufacturing Market Shows Impressive 7.8% CAGR and US$ 40.9 billion by 2032 in Market Growth – By PMI

Covina, Oct. 10, 2023 (GLOBE NEWSWIRE) — Biopharmaceutical products are made from living cells and thus, behaves differently as compared to traditional pharmaceutical products. Next-Generation Biomanufacturing help in improving scalability, efficiency, sustainability and cost-effectiveness in manufacturing processes of biologics.Growing adoption of digital technology and growing trend of AI (artificial intelligence) in bio manufacturing to increase quality of product with reduced cost have provided lucrative opportunities in target market growth. Further, outbreak of pandemic such as COVID-19 has boom the biopharmaceutical industry fuelling the growth of Next-Generation Bio manufacturing market.
Asking questions? Click hereBy ApplicationBy End-UsersEuropeAsia PacificLatin AmericaMiddle East & Africa
(GlobeNewsWire)